A co-founder and co-leader of the firm’s Psychedelics and Emerging Therapies Practice Group, Natasha advises clients on the regulatory matters inherent in new drug development. She also advises behavioral health clients on compliance matters. Natasha approaches her practice with great passion for the promise of psychedelics and other new drugs….
View more
Kimberly is a leading member of the psychedelic law practice group at Husch Blackwell. As a former research scientist for biotech startups, Kimberly has a unique perspective in the emerging area of psychedelic therapeutics. She keeps current on the academic and commercial research and drug discovery efforts in this rapidly…
View more